University Hospital Hamburg-Eppendorf
2cureX receives EU grant for its ovarian cancer project
Yesterday, on World Cancer Day, 2cureX announced that the company's recently launched predictive medicine product, IndiTreat, has been selected for use in...
2cureX and partners receive EUR 1 million for automation of IndiTreat
During the week, 2cureX acquired German subsidiaries, together with...
Contribution injection into 2cureX ovarian cancer initiative
Immuno-oncology is an exciting field that, due to...